Article
Clinical Application of MicroRNA Testing in Neuroendocrine Tumors of the Gastrointestinal Tract
21 Feb 2014
Abstract excerpt
It is well documented that dysregulation of microRNAs is a hallmark of human cancers. Thus, this family of small non-coding regulatory molecules represents an excellent source of sensitive biomarkers. Unique microRNAs expression profiles have been associated with different types and subsets of gastrointestinal tumors including gastroenteropancreatic neuroendocrine tumors (GEP-NETs). GEP-NETs are a heterogeneous...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
